ライフサイエンスコーパス: nucleic acid amplification

1 sufficiently pure to support high-efficiency nucleic acid amplification.

2 ccurate thermal control and the detection of nucleic acid amplification.

3 pe biosensor compared favorably to those for nucleic acid amplification.

4 body tests were tested again with the use of nucleic acid amplification.

5 ng aptamer labels, hybridization assays, and nucleic acid amplification.

6 chomatis were detected from vaginal swabs by nucleic acid amplification.

7 tion of single-cell genomic DNA using linear nucleic acid amplification.

8 ons were identified only with the use of the nucleic acid amplification algorithm.

9 dimensionality and sensitive detection using nucleic acid amplification and analysis techniques.

10 echnologies for milk analysis, in particular nucleic acid amplification and biosensors, is reviewed h

11 Integrating sample preparation with nucleic acid amplification and detection in a cost-effec

12 Nucleic acid amplification and detection plays an increa

13 ne clinical laboratory use by automating the nucleic acid amplification and detection processes.

14 y describe recent developments in isothermal nucleic acid amplification and detection, and focus on e

15 using simple methods of sequence-independent nucleic acid amplification and limited sequencing.

16 The assay involved multiplex nucleic acid amplification and microarray hybridization

17 x priming amplification, to greatly simplify nucleic acid amplification and real-time quantification

18 other biological assays, such as isothermal nucleic acid amplification and restriction enzyme digest

19 Direct molecular assay (ST Direct) relies on nucleic acid amplification and solid array-based amplico

20 rmined the prevalence of HCV RNA by means of nucleic acid amplification and the genotype by means of

21 munoassays, and orthogonal, multiplexed PCR (nucleic acid) amplification and detection.

22 or microbial nucleic acid enrichment, random nucleic acid amplification, and automated sequence simil

23 been utilised to develop a novel isothermal nucleic acid amplification assay (SMART) for the detecti

24 icroscopy with the GeneXpert MTB/RIF (Xpert) nucleic acid amplification assay could reduce testing ti

25 utomated assay provides a useful alternative nucleic acid amplification assay for clinical laboratori

26 nty that contamination has occurred during a nucleic acid amplification assay in the absence of a pos

27 latform in which a simple, dry-reagent-based nucleic acid amplification assay is combined with a port

28 We have developed a specific and sensitive nucleic acid amplification assay that is suitable for ro

29 e potential of combining a dry-reagent-based nucleic acid amplification assay with an electrochemical

30 ion window duration was demonstrated using a nucleic acid amplification assay, the Procleix HIV-1/HCV

31 verse transcription PCR (RT-PCR), and TaqMan nucleic acid amplification assays for the rapid detectio

32 Nucleic acid amplification assays had limited abilities

33 In addition, all three types of nucleic acid amplification assays have been used to dete

34 assay to results from two currently approved nucleic acid amplification assays in 1,722 female and 1,

35 While all three types of nucleic acid amplification assays provide rapid detectio

36 Isothermal nucleic acid amplification assays such as the loop media

37 croBAR is capable of carrying out isothermal nucleic acid amplification assays with real-time fluores

38 When used in nucleic acid amplification assays, gene detection is hom

39 o the species level by phenotypic systems or nucleic acid amplification assays.

40 edure has not transformed the application of nucleic acid amplification assays.

41 Clinical diagnostic tests based on nucleic acid amplification assist with the prompt diagno

42 lood products can be achieved by a sensitive nucleic acid amplification-based assay.

43 ey components necessary to expand the use of nucleic acid amplification-based detection assays toward

44 king this region a target of choice for most nucleic acid amplification-based detection assays.

45 mic range for the new Xpert MTB/RIF assay, a nucleic acid amplification-based diagnostic system that

46 Use of nucleic acid amplification-based diagnostic tests on fir

47 Molecular typing is an important adjunct to nucleic acid amplification-based diagnostics.

48 Alere i Influenza A&B is an isothermal nucleic acid amplification-based integrated system for d

49 rains from direct clinical samples used with nucleic acid amplification-based tests.

50 assembly (CHA) is one of the most promising nucleic acid amplification circuits based on toehold-med

51 he sensitivity, specificity, and rapidity of nucleic acid amplification demonstrate the usefulness of

52 pped with a sample pretreatment device and a nucleic acid amplification device for the rapid diagnosi

53 ave been made in the development of portable nucleic acid amplification devices for near-patient use.

54 ction of viral RNA in both tests is based on nucleic acid amplification followed by hybridization to

55 Nucleic acid amplification includes both polymerase chai

56 erebrospinal fluid (CSF) and the presence of nucleic acid amplification inhibitors.

57 Nucleic acid amplification is an essential process in bi

58 Isothermal nucleic acid amplification is becoming increasingly impo

59 integrated with real-time DNA/RNA isothermal nucleic acid amplification: Loop-mediated isothermal amp

60 acement amplification (SDA) is an isothermal nucleic acid amplification method based on the primer-di

61 ation (LAMP) of DNA is a powerful isothermal nucleic acid amplification method that can generate upwa

62 est, Staph ID/R, combines a rapid isothermal nucleic acid amplification method, helicase-dependent am

63 (CDC) recommends the performance of a direct nucleic acid amplification method, regardless of smear r

64 We recently reported a novel isothermal nucleic acid amplification method, Strand Invasion-Based

65 Often, a more sensitive nucleic acid amplification method, such as PCR, is requi

66 Using the DNase-sequence-independent viral nucleic acid amplification method, we identified several

67 Real-time nucleic acid amplification methods can be extremely usef

68 Our results show that nucleic acid amplification methods can serve to detect C

69 aboratory diagnosis, rapid antigen tests and nucleic acid amplification methods may also play a usefu

70 Isothermal nucleic acid amplification methods offer significant adv

71 Nucleic acid amplification methods such as the PCR have

72 Current nucleic acid amplification methods to detect Mycobacteri

73 and other NGU pathogens were detected using nucleic acid amplification methods, and DNA sequencing w

74 For nucleic acid amplification methods, controlled DNA denat

75 hese limitations, with a focus on isothermal nucleic acid amplification methods.

76 g of both isothermal and temperature-cycling nucleic acid amplification methods.

77 xponential target amplifications provided by nucleic acid amplification methods.

78 and Prevention's Mycobacterium tuberculosis nucleic acid amplification (NAA) evaluation program, 27.

79 nder conditions appropriate for evaluating a nucleic acid amplification (NAA) test for Chlamydia trac

80 llent performance of rapid tuberculosis (TB) nucleic acid amplification (NAA) tests and the clear ben

81 t system (BD Affirm VPIII) was compared with nucleic acid amplification (NAA)-based assays for determ

82 Nucleic acid amplification of biomarkers is increasingly

83 equencing DNA microarrays with either random nucleic acid amplification or multiplex PCR for GAS dete

84 Currently available nucleic acid amplification platforms for tuberculosis (T

85 c devices of the most popular technology for nucleic acids amplifications, polymerase chain reaction

86 ntial, numerous technical issues, especially nucleic acid amplification, probe specificity, and inter

87 n developed from an understanding of natural nucleic acid amplification processes.

88 ircuitry can be used to transduce isothermal nucleic acid amplification products into signals that ca

89 g and transducing signals at the terminus of nucleic acid amplification reactions.

90 on-specific amplification in EXPAR and other nucleic acid amplification reactions.

91 integration of blood sample preparation and nucleic acid amplification reactions.

92 idic systems for the compartmentalization of nucleic acid amplification reactions.

93 field effect transistor methods for sensing nucleic acid amplification rely on establishing the flui

94 nical laboratory include biological culture, nucleic acid amplification, ribosomal protein characteri

95 ing was observed, the failure was due to the nucleic acid amplification step rather than limitations

96 Nucleic acid amplification strategies and advances in am

97 C. difficile assay is an integrated, closed, nucleic acid amplification system that automates sample

98 ert Flu Assay cartridge is a next-generation nucleic acid amplification system that provides multiple

99 ation of DNA (LAMP) is a powerful isothermal nucleic acid amplification technique that can accumulate

100 esults in the negative gray zone by use of a nucleic acid amplification technique, is not suitable fo

101 (MTD) is a rapid diagnostic test based on a nucleic acid amplification technique, which can be used

102 omewhat limited applications of this classic nucleic acid amplification technique.

103 Performing nucleic acid amplification techniques (NAATs) in digital

104 Nucleic acid amplification techniques (polymerase chain

105 ion of these methods that are independent of nucleic acid amplification techniques and could largely

106 Nucleic acid amplification techniques for the diagnosis

107 Recent advances in nucleic acid amplification techniques have allowed for q

108 Nucleic acid amplification techniques have been among th

109 Several nucleic acid amplification techniques have been develope

110 Recent developments in nucleic acid amplification techniques now allow the rapi

111 Nucleic acid amplification techniques such as the PCR ar

112 broad range of assays, including isothermal nucleic acid amplification techniques, enzyme-based immu

113 cluding both antigen detection and multiplex nucleic acid amplification techniques, is becoming more

114 re hospitals were tested for influenza using nucleic acid amplification techniques.

115 Rapid isothermal nucleic acid amplification technologies can enable diagn

116 The availability of nucleic acid amplification technologies may make noninva

117 o known as hyperbranched RCA) are isothermal nucleic acid amplification technologies that have gained

118 first international standard for HBV DNA for nucleic acid amplification technology (NAT) assays.

119 study period, which was analyzed relative to nucleic acid amplification technology (NAT) yield to est

120 ncy virus type 1 (HIV-1) RNA copy numbers by nucleic acid amplification technology (the NASBA HIV-1 R

121 in the input volume of specimens analyzed by nucleic acid amplification technology can be useful for

122 e compared to those from culture and the LCx nucleic acid amplification test (Abbott Industries, Abbo

123 ratory viral panel (eSensor RVP) multiplexed nucleic acid amplification test (GenMark Diagnostics, In

124 FilmArray Respiratory Panel (RP) multiplexed nucleic acid amplification test (Idaho Technology, Inc.,

125 This work presents an on-chip isothermal nucleic acid amplification test (iNAAT) for the multiple

126 sitive for stx by an alternative FDA-cleared nucleic acid amplification test (NAAT) but were negative

127 2) is a Food and Drug Administration-cleared nucleic acid amplification test (NAAT) for the detection

128 The Abbott RealTime MTB assay is a nucleic acid amplification test (NAAT) for the detection

129 To investigate the performance of a nucleic acid amplification test (NAAT) for the diagnosis

130 atis or N. gonorrhoeae, two or more positive nucleic acid amplification test (NAAT) results, or a sin

131 seria gonorrhoeae (gonococcus [GC])-positive nucleic acid amplification test (NAAT) results: (i) repe

132 Culture and a nucleic acid amplification test (NAAT) were used to dete

133 s and symptoms, in contrast with only 3 of 8 nucleic acid amplification test (NAAT)-based studies (P

134 sistant tuberculosis (MDR-TB) screening, all nucleic acid amplification test (NAAT)-positive respirat

135 even more specific if it were compared to a nucleic acid amplification test (NAAT).

136 ave developed an economical, high-throughput nucleic acid amplification test (NAT) for blood-borne vi

137 sts (wet mount, culture, a rapid test, and a nucleic acid amplification test [NAAT]) were performed o

138 ,749 vulvovaginal-swab specimens with both a nucleic acid amplification test and a polymer conjugate-

139 true-negative or false-negative relative to nucleic acid amplification test and/or enzyme immunoassa

140 The Alere i strep A test is an isothermal nucleic acid amplification test designed to offer highly

141 at first vaginal intercourse and a positive nucleic acid amplification test for sexually transmitted

142 ple, sample-to-answer, on-demand, multiplex, nucleic acid amplification test for syndromic diagnosis

143 Qiagen artus C. difficile QS-RGQ kit, a new nucleic acid amplification test for the detection of Clo

144 opment of an internally controlled multiplex nucleic acid amplification test for the detection of den

145 Rapid implementation of a nucleic acid amplification test led to the prospective i

146 defined as a confirmed positive result on a nucleic acid amplification test or as HIV antibody seroc

147 In addition, positive nucleic acid amplification test results should be confir

148 The Xpert MTB/RIF (Xpert) assay is a rapid nucleic acid amplification test widely used in settings

149 t results were resolved using an alternative nucleic acid amplification test.

150 ify reactive specimens for confirmation by a nucleic acid amplification test.

151 t MTB/RIF (Xpert), a novel, semiautomated TB nucleic-acid amplification test, has renewed interest in

152 of 3 algorithms that detect AHI based on HIV nucleic acid amplification testing (EarlyTest algorithm)

153 Here we report the development of a mobile nucleic acid amplification testing (mobiNAAT) platform u

154 utility of Mycobacterium tuberculosis direct nucleic acid amplification testing (MTD) for pulmonary t

155 rator for improving the harmonization of BKV nucleic acid amplification testing (NAAT) and enabling c

156 tion of Chlamydia trachomatis were tested by nucleic acid amplification testing (NAAT) and in cell cu

157 We evaluated criteria to reduce unnecessary nucleic acid amplification testing (NAAT) for viral path

158 Nucleic acid amplification testing (NAAT) has become the

159 Nucleic acid amplification testing (NAAT) is increasingl

160 Nucleic acid amplification testing (NAAT) is the preferr

161 virus infection (AHI); however, the cost of nucleic acid amplification testing (NAAT) makes individu

162 onreactive samples were pooled and tested by nucleic acid amplification testing (NAAT) to identify ac

163 Cervical culture and nucleic acid amplification testing (NAAT) were completed

164 However, nucleic acid amplification testing (NAAT) with the Xpert

165 chomatis infection in certain populations by nucleic acid amplification testing (NAAT), as they invol

166 This study presents the verification of nucleic acid amplification testing (NAAT; Gen-Probe Apti

167 ccepted for transplantation.Universal use of nucleic acid amplification testing (NAT) for the screeni

168 igenic organisms (toxigenic culture [TC] and nucleic acid amplification testing [NAAT]) are confounde

169 The primary outcome was microbial cure by nucleic acid amplification testing at day 28.

170 imens, a useful characteristic in the age of nucleic acid amplification testing for gonococcal infect

171 For all urine specimens, UA, culture, and nucleic acid amplification testing for Neisseria gonorrh

172 North Carolina has added nucleic acid amplification testing for the human immunod

173 f C. trachomatis- or N. gonorrhoeae-specific nucleic acid amplification testing in this metropolitan

174 the introduction of diagnostic M. genitalium nucleic acid amplification testing including antimicrobi

175 Nucleic acid amplification testing is a very powerful me

176 These data support the use of targeted nucleic acid amplification testing of individual donatio

177 Although nucleic acid amplification testing of minipools of blood

178 To determine the effect of nucleic acid amplification testing on the yield and accu

179 Screening of broth enrichment fluids by nucleic acid amplification testing requires careful hand

180 The addition of nucleic acid amplification testing to an HIV testing alg

181 tly, some laboratories have begun adding HIV nucleic acid amplification testing to HIV diagnostic tes

182 est yield on minipool testing, retrospective nucleic acid amplification testing was performed on indi

183 dictive value of the algorithm that included nucleic acid amplification testing were greater than 0.9

184 Although nucleic acid amplification testing would detect N. gonor

185 specimens, known to be gonorrhea positive by nucleic acid amplification testing, provided by females

186 treatment failure determined on the basis of nucleic acid amplification testing, sexual history, and

187 erpretation of gonorrhea tests of cure using nucleic acid amplification testing, this study examined

188 acutely viremic blood donors, identified by nucleic acid amplification testing, were enrolled and mo

189 in whom WNV infection was identified by WNV nucleic acid amplification testing.

190 ts and laboratory-based specimen pooling for nucleic acid amplification testing.

191 other month were tested for M. genitalium by nucleic acid amplification testing.

192 ymptomatic sexual health screening underwent nucleic acid amplification testing; positive samples and

193 Minipool nucleic acid-amplification testing has helped prevent th

194 rmed to be positive for HIV-1 and HCV RNA on nucleic acid-amplification testing of "minipools" (pools

195 The addition of nucleic acid-amplification testing to the screening of t

196 We describe the adoption of nucleic acid amplification tests (NAAT) for Clostridium

197 testing practices since the introduction of nucleic acid amplification tests (NAAT), we surveyed lab

198 uction of rapid serologic tests (RT) and HIV nucleic acid amplification tests (NAAT).

199 Commercial nucleic acid amplification tests (NAATs) are becoming av

200 lty of culture of this fastidious bacterium, nucleic acid amplification tests (NAATs) are necessary f

201 Nucleic acid amplification tests (NAATs) are quickly bec

202 Nucleic acid amplification tests (NAATs) are reliable to

203 ning from toxin enzyme immunoassays (EIA) to nucleic acid amplification tests (NAATs) as the primary

204 Nucleic acid amplification tests (NAATs) can be used to

205 Because nucleic acid amplification tests (NAATs) do not distingu

206 suggested approaches for confirming positive nucleic acid amplification tests (NAATs) for Chlamydia t

207 The greater sensitivity of nucleic acid amplification tests (NAATs) for Chlamydia t

208 is study was to determine the added value of nucleic acid amplification tests (NAATs) for detection o

209 cent sexual assault survivors include use of nucleic acid amplification tests (NAATs) for detection o

210 Nucleic acid amplification tests (NAATs) for enterovirus

211 rapid development of commercially available nucleic acid amplification tests (NAATs) for influenza v

212 r, the true limitation in the realization of nucleic acid amplification tests (NAATs) for near-patien

213 udy evaluated the performance of culture and nucleic acid amplification tests (NAATs) for rectal chla

214 Nucleic acid amplification tests (NAATs) for the detecti

215 Currently, there are no FDA-approved nucleic acid amplification tests (NAATs) for the detecti

216 was to define the performance of culture and nucleic acid amplification tests (NAATs) for the diagnos

217 The currently available nucleic acid amplification tests (NAATs) for trichomonia

218 self-obtained vaginal specimens processed by nucleic acid amplification tests (NAATs) has significant

219 Recently, nucleic acid amplification tests (NAATs) have been appro

220 ple, recent studies with ribosomal RNA-based nucleic acid amplification tests (NAATs) have demonstrat

221 Nucleic acid amplification tests (NAATs) have frequently

222 Nucleic acid amplification tests (NAATs) have revolution

223 DTs), digital immunoassays (DIAs), and rapid nucleic acid amplification tests (NAATs) in children and

224 a CT (ACT) (Hologic Inc., San Diego, CA) are nucleic acid amplification tests (NAATs) that detect Chl

225 . Food and Drug Administration (FDA)-cleared nucleic acid amplification tests (NAATs) to culture usin

226 The use of nucleic acid amplification tests (NAATs) to diagnose Nei

227 The specificity of nucleic acid amplification tests (NAATs) used for early

228 ribing the diagnostic performance of malaria nucleic acid amplification tests (NAATs) using these spe

229 , and illumigene group B Streptococcus (GBS) nucleic acid amplification tests (NAATs) were compared t

230 At that time, nucleic acid amplification tests (NAATs) were just becom

231 ests for Chlamydia trachomatis have compared nucleic acid amplification tests (NAATs) with diagnostic

232 The use of nonculture methods, such as nucleic acid amplification tests (NAATs), to evaluate pr

233 tinct MAMEF assays were compared to those of nucleic acid amplification tests (NAATs).

234 rus (DENV) detection, including a variety of nucleic acid amplification tests (NAATs).

235 sed to confirm the results of more sensitive nucleic acid amplification tests (NAATs).

236 lticenter study evaluated that specimen with nucleic acid amplification tests (NAATs).

237 ulture-based systems, simplified versions of nucleic acid amplification tests (such as the Xpert MTB/

238 ine whether test performance measures of two nucleic acid amplification tests and a DNA probe were af

239 tive donations were confirmed by alternative nucleic acid amplification tests and IgM and IgG tests,

240 es and gaining in use are techniques such as nucleic acid amplification tests and mass spectroscopy t

241 Nucleic acid amplification tests and point-of-care tests

242 genitalium coinfections were evaluated using nucleic acid amplification tests and were negative at 1

243 Nucleic acid amplification tests are accurate for diagno

244 proaches to diagnosis remain inaccurate, and nucleic acid amplification tests are also compromised by

245 Nucleic acid amplification tests are increasingly used t

246 ting areas of the clinical spectrum in which nucleic acid amplification tests can make an important c

247 In 10 new studies of asymptomatic patients, nucleic acid amplification tests demonstrated sensitivit

248 Nucleic acid amplification tests detected CT, MG, and TV

249 gonorrhoeae and Chlamydia trachomatis using nucleic acid amplification tests detects greater numbers

250 ly impact the performance characteristics of nucleic acid amplification tests for B. pertussis.

251 Results of nucleic acid amplification tests for C. trachomatis on u

252 We evaluated the performance of two nucleic acid amplification tests for detecting Chlamydia

253 We compared two rapid, point-of care nucleic acid amplification tests for detection of influe

254 Since diagnostic nucleic acid amplification tests for gonococci are now i

255 between liquid cytologic media and multiple nucleic acid amplification tests for the detection of C.

256 In laboratory trials, nucleic acid amplification tests for the diagnosis of tu

257 ree commercial identification kits and three nucleic acid amplification tests for the identification

258 Nucleic acid amplification tests for Trichomonas vaginal

259 Nucleic acid amplification tests have become a common me

260 While nucleic acid amplification tests have great potential as

261 Nucleic acid amplification tests identify BI/NAP1/027 ra

262 dia trachomatis and Neisseria gonorrhoeae by nucleic acid amplification tests is an attractive altern

263 The use of nucleic acid amplification tests of "minipools" of 16 sa

264 ions and the incremental yield and safety of nucleic acid amplification tests of individual donations

265 Nucleic acid amplification tests offer superior sensitiv

266 retrospectively using enzyme immunoassay and nucleic acid amplification tests on stored specimens.

267 nd discrepancies were resolved by additional nucleic acid amplification tests or sequencing.

268 The increased sensitivities of nucleic acid amplification tests such as ligase chain re

269 In many clinical microbiology laboratories, nucleic acid amplification tests such as PCR have become

270 Nucleic acid amplification tests such as PCR have signif

271 Nucleic acid amplification tests such as the BDProbeTec

272 y have residual DNA in sputum that confounds nucleic acid amplification tests such as Xpert MTB/RIF.

273 rovide valid specimens for HPV testing using nucleic acid amplification tests, although a few cytolog

274 imens from women are suitable substrates for nucleic acid amplification tests, but enzyme immunoassay

275 strategies, newer testing methods, including nucleic acid amplification tests, have enhanced sensitiv

276 Emerging POC microbiology tests, especially nucleic acid amplification tests, have the potential to

277 n will expand the diagnostic applications of nucleic acid amplification tests, in particular for near

278 that evaluated 1 of 3 commercially available nucleic acid amplification tests, included data from tes

279 Development of nucleic acid amplification tests, such as the ligase cha

280 With a reference standard of two different nucleic acid amplification tests, the sensitivity and sp

281 (UU-2), and Trichomonas vaginalis (TV) using nucleic acid amplification tests.

282 There were two false positive results on nucleic acid amplification tests.

283 reatly expand the diagnostic applications of nucleic acid amplification tests.

284 le virus RNA with the use of investigational nucleic acid amplification tests; testing was performed

285 lection agencies implemented West Nile virus nucleic acid-amplification tests to identify infected do

286 e respective rates of positive HCV and HIV-1 nucleic acid-amplification tests were 3.3 and 4.1 times

287 horolysis-activated polymerization [PAP]) of nucleic acid amplification that uses 3' blocked primers

288 e quantitative electrochemical monitoring of nucleic acid amplification through PCR is a promising re

289 Electrical detection of nucleic acid amplification through pH changes associated

290 urists and restaurant staff were examined by nucleic acid amplification using reverse transcription p

291 -activated polymerization (PAP), a method of nucleic acid amplification using serial coupling of pyro

292 and hepatitis C virus (HCV) RNA by means of nucleic acid amplification was introduced in the United

293 Real-time nucleic acid amplification, whereby the amplification ra